Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in graves' disease

Thyroid

Volumn 11, Issue 6, 2001, Pages 575-580

  Zantut Wittmann, D E ^a   Tambascia, M A ^a   Da Silva Trevisan, M A ^a   Pinto, G A ^a   Vassallo, J ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; HLA DR ANTIGEN; LEVOTHYROXINE; PROPYLTHIOURACIL; THIAMAZOLE;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; DISEASE CONTROL; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; PRIORITY JOURNAL; REMISSION; THYROID FOLLICLE CELL; THYROTOXICOSIS;

EID: 0034948747     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072501750302886     Document Type: Article

References (29)

1. Autoimmune thyroid disease
2. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions
3. Antigen processing and intracellular la. Possible roles of endocytosis and protein synthesis in la function
4. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: Relevance for autoimmunity
5. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity
6. Enhancement of thyroid HLA class II expression by thyroid-stimulating hormone
7. A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil
8. Direct effect of methimazole on rat thyroidal cell growth induced by thyrotropin and insulin-like growth factor I
9. Antithyroid drug effects on function and growth of FRTL-5 cells
10. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease
11. Regulation of major histocompatibility class II gene expression in ERTL-5 thyrocytes: Opposite effects of interferon and methimazole
12. Inhibition of immunoglobulin-secreting cells by anti-thyroid drugs
13. Lymphoid tissue in the thyroid gland and thymus of patients with primary thyrotoxicosis
14. The effect of radioiodine and thyroid drugs on serum long acting thyroid stimulator protector (LATS-P). A three year prospective study
15. Carbimazole and the autoimmune response in Graves' disease
16. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease
17. Intrathyroidal concentrations of methimazole in patients with Graves' disease
18. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedure
19. Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression
20. Effects of recombination human interleukin-2 and tumor necrosis factor with or without interferon gamma on human thyroid tissue from patients with Graves' disease and from normal subjects xenografted into nude mice
21. Autoimmune thyroid disease: Further developments in our understanding
22. The influence of triiodothyronine , thyroxin, thyrotropin and methimazole on thyroid cell MHC class II antigen expression
23. Studies of HLA-DR expression on cultured human thyrocytes: Effect of antithyroid drugs and other agents on interferon gamma-induced HLA-DR expression
24. Antithyroid drugs
25. Lymphokine regulation of HLA-DR gene expression in human thyroid cell monolayers
26. The influence of antithyroid drugs and iodine on thyroid cell MHC class II antigen expression
27. The in vitro suppression of lectin induced 3H-thymidine incorporation into DNA of peripheral blood lymphocytes after the addition of propylthiouracil
28. The immunosuppressive effect of methimazole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals
29. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic goiter and Graves' disease